Management of Graves' ophthalmopathy: reality and perspectives.
about
Recent developments in thyroid eye diseaseGraves' Ophthalmopathy: VISA versus EUGOGO Classification, Assessment, and ManagementCritical Appraisal on Orbital Decompression for Thyroid Eye Disease: A Systematic Review and Literature SearchGraves' ophthalmopathyProtocol for the combined immunosuppression & radiotherapy in thyroid eye disease (CIRTED) trial: a multi-centre, double-masked, factorial randomised controlled trial.Clinical characteristics of moderate-to-severe thyroid associated ophthalmopathy in 354 Chinese cases.Assessment of quality of life and depression in Korean patients with Graves' ophthalmopathy.The relationship between sex and symmetry in thyroid eye diseaseThyroid-associated orbitopathy.Quercetin inhibits IL-1β-induced inflammation, hyaluronan production and adipogenesis in orbital fibroblasts from Graves' orbitopathy.Radiotherapy in the treatment of Graves ophthalmopathy-to do it or not?Risk factors associated with the severity of thyroid-associated orbitopathy in Korean patients.Semiautomatic regional segmentation to measure orbital fat volumes in thyroid-associated ophthalmopathy. A validation studyEfficacy and safety of low dose oral prednisolone as compared to pulse intravenous methylprednisolone in managing moderate severe Graves' orbitopathy: A randomized controlled trial.Thyrotropin receptor and CD40 mediate interleukin-8 expression in fibrocytes: implications for thyroid-associated ophthalmopathy (an American Ophthalmological Society thesis)Outcome of thyroid associated ophthalmopathy treated by radiation therapyBilateral versus unilateral thyroid eye diseaseColor Doppler imaging of the superior ophthalmic vein in patients with Graves' orbitopathy before and after treatment of congestive disease.Effect of radiotherapy on moderate and severe thyroid associated ophthalmopathy: a double blind and self-controlled study.Analytical and diagnostic accuracy of "second generation" assays for thyrotrophin receptor antibodies with radioactive and chemiluminescent tracers.The evolving role of selenium in the treatment of graves' disease and ophthalmopathy.Common Immunosuppressive Monotherapy for Graves' Ophthalmopathy: A Meta-Analysis.Thyroid Stimulating but Not Blocking Autoantibodies Are Highly Prevalent in Severe and Active Thyroid-Associated Orbitopathy: A Prospective StudyEfficacy of Subantimicrobial Dose Doxycycline for Moderate-to-Severe and Active Graves' Orbitopathy.Assessing Graves' ophthalmopathy-specific quality of life in Korean patients.Radioiodine I-131 for the therapy of graves' disease.Thyroid associated orbitopathy.Development of a Novel Thyroid Function Fluctuated Animal Model for Thyroid-Associated OphthalmopathyGenetic profiling in Graves' disease: further evidence for lack of a distinct genetic contribution to Graves' ophthalmopathy.Usefulness of the ratio of orbital fat to total orbit area in mild-to-moderate thyroid-associated ophthalmopathy.Relationship between magnetic resonance imaging signal intensity and volume of extraocular muscles in thyroid-associated ophthalmopathy with methylprednisolone pulse therapy.Optic Neuropathy in Thyroid Eye Disease: A Case SeriesOrbital decompression surgery and horse chestnut seed extract improved superior orbital vein blood flow in patients with thyroid-associated ophthalmopathyComparison of Early Total Thyroidectomy with Antithyroid Treatment in Patients with Moderate-Severe Graves' Orbitopathy: A Randomized Prospective TrialDiagnosis and stage of Graves' ophthalmopathy: Efficacy of quantitative measurements of the lacrimal gland based on 3-T magnetic resonance imaging.Compressive Optic Neuropathy and Repeat Orbital Decompression: A Case Series.Is Recombinant Human TSH a Trigger for Graves' Orbitopathy?Effects of prostaglandin F(2α) on adipocyte biology relevant to graves' orbitopathy.Update on thyroid eye disease and management.Spontaneous improvement of untreated mild Graves' ophthalmopathy: Rundle's curve revisited.
P2860
Q24564205-74CBD2BD-F3F3-4DAB-95CD-BE1AB272CB70Q26782424-963F316C-CC00-4863-8598-301CB50D30FEQ26800562-C482BA77-4F31-44AA-AA84-B872F0DF05B6Q28274196-EC703FE2-054F-4252-ABCD-03B095FB8F92Q30481543-9E65C5B5-BC02-4986-9D05-093BEBB11883Q33637524-BAF25C5B-3F5E-4D34-B50A-C11326F40629Q33774785-8C790C41-2199-4DC1-B975-02D0357ECA9EQ33895382-86E9E72D-516F-4572-8498-B7EDAEAD0134Q33910021-F4153F8C-FD0E-4803-96FE-9C0B00F89B20Q34062319-57A37B32-B5A8-4336-B770-92DEA52A7AF6Q34102362-20139F9C-DAA3-4714-ABE9-A6D42050A79AQ34200995-F9CD163B-F765-42B5-BF05-604CC05E704EQ34369410-49EC8481-B989-4649-A994-51ADF3414229Q34474593-AF72C33A-460C-43EA-86C3-E1E51F4BD147Q34525298-9955AF2D-15A8-4274-A7DF-672A4C79CE7EQ35025267-BFA52812-3601-44BE-8D1C-CCD86E409E04Q35174246-43E40C91-8467-40D6-A212-DDDFDB2B9BCAQ35179672-7208BBD9-97C8-4B79-9158-77EEBE497593Q35479930-60DF230B-5FE7-4F79-8B05-68CE5FF2A188Q35587522-8F229670-4EF6-4DED-BA0D-7DB25654F147Q35725329-04B55054-E5B0-44B1-803D-FEE82232AF0DQ35808258-F24F9DDF-3D8F-4D99-BE65-9846AB79245EQ35843186-0B1BFF37-378D-4B7D-A946-4887DC80EC3FQ35843863-DADC4A99-73F7-49B5-8413-2E1F197CAF18Q35886822-533C5346-C51D-4FDA-BD45-78330616213BQ35911969-655CACBC-CBAB-4068-AEE9-7DB5FB568AFAQ35919247-A06D1240-D51A-44B0-9B33-40A8F2DC62A2Q35922627-FB86F8C0-55DA-4CD7-8733-3E44796E325EQ36070800-A50257B7-C04A-4F1E-90E9-C951090FF8E0Q36550941-AFA9AA22-D14D-4AE6-A644-52DBC662C4E2Q36833918-8710D3C0-3728-411E-A4B3-4FFF245DA47EQ36963786-5D078EB9-BE12-4757-99B7-F47E7D357480Q37026793-74C2F082-3A11-4F40-B63F-DC52A8811DD2Q37104833-F9E410D5-0B5D-41E4-B0DA-1BBC2565E276Q37108158-3558DD18-F0C9-4415-B21C-1A0D7AA94AC1Q37283088-A7788BDA-658F-47F7-8C25-610B04FAF420Q37290852-488F686F-EFE7-4FEA-911D-26566C0B6D63Q37404274-23462193-3152-43E5-B7E1-74AADD866AE7Q37406589-1C4EBB9A-5802-4992-92C5-23A000891F89Q37460205-C9613FAB-55FF-432D-BCFA-9DBDE1C8F09F
P2860
Management of Graves' ophthalmopathy: reality and perspectives.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Management of Graves' ophthalmopathy: reality and perspectives.
@ast
Management of Graves' ophthalmopathy: reality and perspectives.
@en
type
label
Management of Graves' ophthalmopathy: reality and perspectives.
@ast
Management of Graves' ophthalmopathy: reality and perspectives.
@en
prefLabel
Management of Graves' ophthalmopathy: reality and perspectives.
@ast
Management of Graves' ophthalmopathy: reality and perspectives.
@en
P2093
P356
P1433
P1476
Management of Graves' ophthalmopathy: reality and perspectives.
@en
P2093
Bartalena L
Marcocci C
Pinchera A
P304
P356
10.1210/EDRV.21.2.0393
P577
2000-04-01T00:00:00Z